Stay updated with breaking news from Syncona Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Freeline Therapeutics Holdings Plc (FRLN) said on Wednesday that it has inked a deal to be acquired by the newly established portfolio company, Syncona Ltd (SYNC), for around $28.
London-listed Syncona Ltd has agreed to acquire Freeline Therapeutics Holdings plc (NASDAQ: FRLN) in an all-cash transaction for $6.50 per
London-listed Syncona Ltd has agreed to acquire Freeline Therapeutics Holdings plc FRLN in an all-cash transaction for $6.50 per American Depositary Share.…
Syncona Ltd ("Syncona" or the "Company"), a leading life science investor focused on creating, building and scaling global leaders in life science, today announces that its newly established portfolio company has entered into an agreement with Freeline Therapeutics Holdings plc ("Freeline") to acquire all of the ...
Syncona Ltd - London-based investor in healthcare companies - Says portfolio company Achilles Therapeutics reports that pretax loss widened to USD16.7 million in the third quarter of 2023 from...